Understanding Prestroke Cognitive Impairment: Key Findings from Mele et al.’s Study
STROKE CLINICAL STUDY HIGHLIGHTS – Prestroke Cognitive Impairment: Frequency and…
Alvina KhooJuly 29, 2024
Disclaimers: NeuroAiD™ II is a trademark of Moleac. MLC601 and MLC901 are 2 different proprietary formulations which have been shown to be equivalent in pharmacology and are referred as NeuroAiD on this webpage.